Xiaoda Niu

1.6k total citations
17 papers, 869 citations indexed

About

Xiaoda Niu is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Xiaoda Niu has authored 17 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Xiaoda Niu's work include Immune Response and Inflammation (6 papers), NF-κB Signaling Pathways (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Xiaoda Niu is often cited by papers focused on Immune Response and Inflammation (6 papers), NF-κB Signaling Pathways (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Xiaoda Niu collaborates with scholars based in United States, Germany and Canada. Xiaoda Niu's co-authors include Daniel Lundell, Satwant K. Narula, Maria Wiekowski, Donald N. Cook, Martin Lipp, Harry B. Greenberg, Jiwen Zhang, Nelly A. Kuklin, Susan J. Abbondanzo and Sérgio A. Lira and has published in prestigious journals such as Immunity, Biochemistry and Journal of Cell Science.

In The Last Decade

Xiaoda Niu

17 papers receiving 847 citations

Peers

Countries citing papers authored by Xiaoda Niu

Since Specialization

Citations

This map shows the geographic impact of Xiaoda Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoda Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoda Niu more than expected).

Fields of papers citing papers by Xiaoda Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoda Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoda Niu. The network helps show where Xiaoda Niu may publish in the future.

Co-authorship network of co-authors of Xiaoda Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoda Niu. A scholar is included among the top collaborators of Xiaoda Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoda Niu. Xiaoda Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Development of a prodrug of hydantoin based TACE inhibitor 2017 ·Bioorganic & Medicinal Chemistry Letters ·Ling Tong, Seong Heon Kim, Lei Chen, (unknown), Bandarpalle B. Shankar, Vinay Girijavallabhan, Deyi Yang, Wensheng Yu, Guowei Zhou, Neng‐Yang Shih, Shiying Chen, Mengwei Hu, Daniel Lundell, Xiaoda Niu, Shelby P. Umland, Joseph A. Kozlowski	5
2	Efforts towards the optimization of a bi-aryl class of potent IRAK4 inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), W. Michael Seganish, William T. McElroy, (unknown), Rui Zhang, Hon‐Chung Tsui, (unknown), Deen Tulshian, James R. Tata, (unknown), Kristine Devito, James Fossetta, Charles G. Garlisi, Daniel Lundell, Xiaoda Niu	13
3	Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4 2015 ·Bioorganic & Medicinal Chemistry Letters ·W. Michael Seganish, William T. McElroy, R. Jason Herr, (unknown), William J. Greenlee, J. P. Harding, Venukrishnan Komanduri, Julius J. Matasi, (unknown), Deen Tulshian, (unknown), Larry Yet, Kristine Devito, James Fossetta, Charles G. Garlisi, Daniel Lundell, Xiaoda Niu, (unknown)	7
4	Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4 2015 ·Bioorganic & Medicinal Chemistry Letters ·William T. McElroy, W. Michael Seganish, R. Jason Herr, J. P. Harding, (unknown), Larry Yet, Venukrishnan Komanduri, (unknown), Brian J. Lavey, Deen Tulshian, William J. Greenlee, (unknown), Thierry Fischmann, Xiaoda Niu	13
5	Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 Inhibitors 2015 ·ACS Medicinal Chemistry Letters ·W. Michael Seganish, Thierry Fischmann, Brad Sherborne, Julius J. Matasi, Brian J. Lavey, William T. McElroy, Deen Tulshian, James R. Tata, (unknown), Charles G. Garlisi, Kristine Devito, James Fossetta, Daniel Lundell, Xiaoda Niu	21
6	Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation 2015 ·ACS Medicinal Chemistry Letters ·William T. McElroy, Zheng Tan, Ginny D. Ho, Sunil Paliwal, Guoqing Li, W. Michael Seganish, Deen Tulshian, James R. Tata, Thierry Fischmann, (unknown), Hong Bian, Loretta A. Bober, J. J. Jackson, Charles G. Garlisi, Kristine Devito, James Fossetta, Daniel Lundell, Xiaoda Niu	34
7	ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site 2010 ·Journal of Cell Science ·Sylvain M. Le Gall, Thorsten Maretzky, Priya D. Issuree, Xiaoda Niu, Karina Reiß, Paul Säftig, Rama Khokha, Daniel Lundell, Carl Blobel	160
8	An Extensive Empirical Study on Semi-supervised Learning 2010 ·Yuanyuan Guo, Xiaoda Niu, Harry Zhang	20
9	Discovery of novel hydroxamates as highly potent tumor necrosis factor-α converting enzyme inhibitors. Part II: Optimization of the S3′ pocket 2008 ·Bioorganic & Medicinal Chemistry Letters ·Robert Mazzola, Zhaoning Zhu, (unknown), Brian A. McKittrick, Brian J. Lavey, (unknown), Joseph A. Kozlowski, (unknown), Guowei Zhou, Zhuyan Guo, Peter Orth, Vincent Madison, (unknown), Daniel Lundell, Xiaoda Niu	28
10	Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Zhuyan Guo, Peter Orth, (unknown), Brian J. Lavey, Neng‐Yang Shih, Xiaoda Niu, Daniel Lundell, Vincent Madison, Joseph A. Kozlowski	24
11	Discovery of Novel Hydroxamates as Highly Potent Tumor Necrosis Factor-α Converting Enzyme Inhibitors: Part I—Discovery of Two Binding Modes 2008 ·Journal of Medicinal Chemistry ·Zhaoning Zhu, Robert Mazzola, (unknown), Brian A. McKittrick, Xiaoda Niu, Daniel Lundell, (unknown), Peter Orth, Zhuyan Guo, Vincent Madison, Richard Ingram, Brian M. Beyer	22
12	IK682, a tight binding inhibitor of TACE 2006 ·Archives of Biochemistry and Biophysics ·Xiaoda Niu, Shelby P. Umland, Richard Ingram, Brian M. Beyer, Yan‐Hui Liu, (unknown), Daniel Lundell, Peter Orth	46
13	Inhibition of fucosyltransferase VII by gallic acid and its derivatives 2004 ·Archives of Biochemistry and Biophysics ·Xiaoda Niu, Xuedong Fan, Jing Sun, Pauline C. Ting, Satwant K. Narula, Daniel Lundell	25
14	CCR6 Mediates Dendritic Cell Localization, Lymphocyte Homeostasis, and Immune Responses in Mucosal Tissue 2000 ·Immunity ·Donald N. Cook, (unknown), Reinhold Förster, Jiwen Zhang, Nelly A. Kuklin, Susan J. Abbondanzo, Xiaoda Niu, Shu‐Cheng Chen, Denise Manfra, Maria Wiekowski, Lisa Sullivan, Sidney R. Smith, Harry B. Greenberg, Satwant K. Narula, Martin Lipp, Sérgio A. Lira	404
15	Expression, Purification, and Characterization of the Dihydrolipoamide Dehydrogenase-Binding Protein of the Pyruvate Dehydrogenase Complex from Saccharomyces cerevisiae 1994 ·Biochemistry ·(unknown), (unknown), Xiaoda Niu, (unknown), Lester J. Reed	36
16	Biochemical and Molecular Genetic Aspects of Eukaryotic Pyruvate Dehydrogenase Multienzyme Complexes 1992 ·Journal of Nutritional Science and Vitaminology ·Lester J. Reed, Janet E. Lawson, Xiaoda Niu, (unknown), S. P. M. FUSSEY	5
17	Biochemical and Molecular Genetic Aspects of Pyruvate Dehydrogenase Complex from Saccharomyces cerevisiae^a 1989 ·Annals of the New York Academy of Sciences ·Lester J. Reed, Karen Browning, Xiaoda Niu, Robert H. Behal, David J. Uhlinger	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact